Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q1

Pharmacoepidemiology and Drug Safety

John Wiley and Sons Ltd

United KingdomPharmacology (medical) (Q1); Epidemiology (Q2)ISSN-matched source record
Journal website ↗
Q1Ranking
2.6Impact Factor (2025)
117H-index (SCImago 2025)
1.041SJR (2025)
1992-2026Coverage

About Pharmacoepidemiology and Drug Safety

Pharmacoepidemiology and Drug Safety is a scholarly journal published by John Wiley and Sons Ltd. SCImago 2025 lists it in Q1, with an SJR of 1.041 and H-index of 117.

Coverage: 1992-2026. Research categories: Pharmacology (medical) (Q1); Epidemiology (Q2).

Verified field sources

  • Editor(s): B.L. Strom, USA; V. Lo Re, USA; Olaf H. Klungel, The Netherlands; B.J. Park, Korea (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
  • Journal Impact Factor: 2.6 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
  • Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.

Source-backed journal facts

ISSN(s)1053-8569, 1099-1557
ISSN-L1053-8569
Source typeJournal
Publisher / hosting organisationWiley
Publisher country codeGB
Fully open access (OpenAlex)Not marked as fully open access; hybrid options may exist
DOAJ flag (OpenAlex)Not listed in OpenAlex metadata; this is not a direct DOAJ check
Works recorded in OpenAlex6,211
Citations recorded in OpenAlex140,280
OpenAlex H-index136
Years represented in OpenAlex1909–2026 (not the founding or closing dates)

Topics in published research

Pharmacovigilance and Adverse Drug Reactions; Pharmaceutical Practices and Patient Outcomes; Pharmaceutical studies and practices; Medication Adherence and Compliance; Advanced Causal Inference Techniques; Health Systems, Economic Evaluations, Quality of Life.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Reported open-access list prices

4,650.00 USD; 3,990.00 EUR; 3,290.00 GBP

APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit